|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-3-5
|
|
pubmed:abstractText |
Systemic transplantation of mesenchymal stem cells (MSC) is known to promote reparative process in a number of tissue damage as well as mucous healing one. It provided the basis for our study which was aimed to the effect of systemic transplantation of allogenic MSC (intravenous transfusion) in complex therapy of patients with Ulcerative Colitis.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1682-8658
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4-12
|
|
pubmed:meshHeading |
pubmed-meshheading:20205326-Adolescent,
pubmed-meshheading:20205326-Adult,
pubmed-meshheading:20205326-Colitis, Ulcerative,
pubmed-meshheading:20205326-Female,
pubmed-meshheading:20205326-Humans,
pubmed-meshheading:20205326-Male,
pubmed-meshheading:20205326-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:20205326-Middle Aged,
pubmed-meshheading:20205326-Remission Induction,
pubmed-meshheading:20205326-Transplantation, Homologous
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
[Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis].
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|
